Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1996-07-11
1999-07-13
Scheiner, Toni R.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
530395, 5303881, 4241361, 4241841, 4242041, 4242341, 4242651, 4242741, 4242771, 536 235, 435 697, C12P 2108, C07K 1628, C07K 1900, A61K 39395
Patent
active
059228458
ABSTRACT:
Therapeutic multispecific compounds comprised of anti-Fc.alpha. receptor antibodies and methods of use are provided.
REFERENCES:
Deo, Y.M. et al. (1997) "Fc.alpha. directed bispecific molecules (BSM) mediate lysis and phagocytosis of tumor cells" Proceedings of the American Association For Cancer Research 38: 30, Abstract No. 195.
Fanger, M.W. et al. (1994) "Production and use of anti-fcr bispecific antibodies" Immunomethods 4: 72-81.
Kettleborough, C.A. et al. (1991) "Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation" Protein Engineering 4(7): 773-783.
McCall, A.M. et al. (1996) "Production of bispecific single-chain Fvs (sFv').sub.2 specific for the oncogene product c-erbB-2 and human CD16/mouse Fc.gamma.RII/III using recombinant phage display libraries" Proceedings of the American Association For Cancer Research 37: 472, Abstract No. 3218.
Weiner, L.M. et al. (1995) "Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc.gamma.RIII" Cancer Research 55: 4586-4593.
Sandhu (J.S.) 1992 Critical Reviews in BioTechnology vol. 12 (5,6) 1992 pp. 437-462.
Alkan, S. et al., "Enhanced Antiproliferative Action of Interferon Targeted by Bispecific Monoclonal Antibodies," Journal of Interferon Research, vol. 8, 25-33 (1988).
Bacus, S. et al., "Expression of the erbB-2 Family of Growth Factor Receptors and their Ligands in Breast Cancers," Am J Clin Pathol, vol. 102, supp. 1, S13-S24 (1994).
Bajorath, J. and Sheriff, S., "Comparison of an Antibody Model with an X-Ray Structure: The Variable Fragment of BR96," Proteins: Structure, Function, and Genetics, vol. 24, 152-157 (1996).
De Potter, C. and Schelfhout, A., "The Neu-Protein and Breast Cancer," Virchows Archiv, vol. 426, 107-115 (1995).
Devilee, P. et al., "Recent Developments in the Molecular Genetic Understanding of Breast Cancer," Critical Reviews in Oncogenesis, vol. 5, No. 2 & 3, 247-270 (1994).
Earp, H. et al., "Heterodimerization and Functional Interaction Between EGF Receptor Family Members: A New Signaling Paradigm with Implications for Breast Cancer Research," Breast Cancer Research and Treatment, vol. 35, 115-132 (1995).
Grossetete, B. et al., "Impaired Fc.alpha. Receptor Expression is Linked to Increased Immunoglobulin A Levels and Disease Progression in HIV-1-Infected Patients," AIDS, vol. 9, 229-234 (1995).
Jardines, L. et al., "neu(c-erbB-2/HER2) and the Epidermal Growth Factor Receptor (EGFR) in Breast Cancer," Pathobiology, vol. 61, 268-282 (1993).
Johnson, G. et al., "Seqhunt: A Program to Screen Aligned Nucleotide and Amino Acid Sequences," Methods in Molecular Biology, vol. 51, ch. 1, 1-15 (1995).
Keler, T. et al., "Bispecific Antibody (MDX-210) Targeting of Tumor Cells to Monocytes Via the Fc Receptor Type I (Fc.gamma.RI) Promotes Antibody Dependent Cellular Cytotoxicity (ADCC) and Induction of Specific Cytokines," Proceedings of the American Association for Cancer Research, vol. 36, 485 (1995).
Kubagawa, H. et al., "Cloning of Genes Encoding Possible Murine Fc.alpha. Receptors (Fc.alpha.R)," FASEB J., vol. 8, No. 4-5, A749 (1994).
Mezzanzanica, D. et al., "Human Ovarian Carcinoma Lysis by Cytotoxic T Cells Targeted by Bispecific Monoclonal Antibodies: Analysis of the Antibody Components," Int. J. Cancer, vol. 41, 609-615 (1988).
Monteiro, R. et al., "Definition of Immunoglobulin A Receptors on Eosinophils and their Enhanced Expression in Allergic Individuals," J. Clin. Invest., vol. 92, 1681-1685 (1993).
Monteiro, R. et al., "Molecular Heterogeneity of Fc.alpha. Receptors Detected by Receptor-Specific Monoclonal Antibodies," The Journal of Immunology, vol. 148, No. 6, 1764-1770 (1992).
Patry, C. et al., "Fc.alpha. Receptors Mediate Release of Tumour Necrosis Factor-.alpha. and Interleukin-6 by Human Monocytes Following Receptor Aggregation," Immunology, vol. 86, 1-5 (1995).
Patry, C. et al., "Identification of Fc.alpha. Receptor (CD89) Isoforms Generated by Alternative Splicing that are Differentially Expressed Between Blood Monocytes and Alveolar Macrophages," The Journal of immunology, vol. 156, 4442-4448 (1996).
Pfefferkorn, L. and Yeaman, G., "Association of IgA-Fc Receptors (Fc.alpha.R) with Fc.epsilon.Rl.gamma.2 Subunits in U937 Cells," The Journal of immunology, vol. 153, 3228-3236 (1994).
Shimada, T. et al., "Comparative Analysis of Fc.alpha.R on Neutrophils and Monocytes," FASEB J., vol. 9, No. 4, A804 (1995).
Shimo, K. et al., "Ligand-Binding Properties of Recombinant Soluble Fc.alpha. Receptor," FASEB J., vol. 9, No. 4, A774 (1995).
Threlkeld, S.C. et al., "Differential Down-Modulation of IgA Fc Receptors (Fc.alpha.R) on Neutrophils and Monocytes in HIV-Infected and Normal Individuals," FASEB J., vol. 8, No. 4-5, A492 (1994).
Valone, F. et al., "Phase Ia/Ib Trial of Bispecific Antibody MDX-210 in Patients with Advanced Breast or Ovarian Cancer that Overexpresses the Proto-Oncogene HER-2
eu," J Clin Oncol, vol. 13, No. 9, 2281-2292 (1995).
Valone, F.H. et al., "Schedule Dependent Immunological Stimulation by Bispecific Antibody (BsAb) MDX-210 (anti-Fc.gamma.RI.times.anti-HER-2
eu) in Patients with Breast or Ovarian Cancers that Over Express HER-2
eu," Proceedings of the American Association for Cancer Research, vol. 36, 500 (1995).
Webster, D. and Rees, A., "Molecular Modeling of Antibody-Combining Sites," Methods in Molecular Biology, vol. 51, 17-49 (1995).
Weisbart, R.H. et al., "GM-CSF Induces Human Neutrophil IgA-Mediated Phagocytosis by an IgA Fc Receptor Activation Mechanism," Nature, vol. 332, 647-648 (1988).
Yeaman, G. and Pfefferkorn, L.C., "IgA-Fc Receptors (Fc.alpha.R) on U937 Cells Associate with Fc.epsilon.RI Gamma Subunits," FASEB J., vol. 8, No. 4-5, A981 (1994).
Deo Yashwant M.
Graziano Robert
Keler Tibor
Bansal Geetha P.
DeConiti, Jr. Giulio A.
Medarex Inc.
Remillard Jane E.
Scheiner Toni R.
LandOfFree
Therapeutic multispecific compounds comprised of anti-Fc.alpha. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic multispecific compounds comprised of anti-Fc.alpha. , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic multispecific compounds comprised of anti-Fc.alpha. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2276530